St. Jude Children’s Research Hospital

St. Jude researchers found that hematopoietic stem cells from children and young adults with sickle cell disease carry premature-senescence features and impaired blood-forming capacity. In xenograft models, senolytic treatment, including dasatinib plus quercetin, reduced…